Cargando…

Effects of Tumor Necrosis Factor and Hyperthermia on Meth‐A Tumors

The combined effects of purified human natural tumor necrosis factor (TNF) and hyperthermia were investigated in a transplanted TNF‐sensitive Meth‐A tumor model. We assessed the sequence and interval for the two treatments, the temperature that caused maximal heat sensitization, and the effects of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiraoka, Masahiro, Li, Yu Ping, Tsutsui, Kazushige, Abe, Mitsuyuki, Yoshiki, Yoshiki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918257/ https://www.ncbi.nlm.nih.gov/pubmed/1955383 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01773.x

Ejemplares similares

Enhancement of Blood Stasis and Vascular Permeability in Meth‐A Tumors by Administration of Hyperthermia in Combination with Tumor Necrosis Factor
por: Umeno, Hiroshi, et al.
Publicado: (1994)

Mechanism of Synergistic Cytotoxic Effect between Tumor Necrosis Factor and Hyperthermia
por: Yamauchi, Naofumi, et al.
Publicado: (1992)

Changes in Cell Proliferative Parameters of SCCVII and EMT6 Murine Tumors after Single‐dose Irradiation
por: Murata, Rumi, et al.
Publicado: (1996)

Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas
Publicado: (1988)

Hyperthermia and Tumor Immunity
por: Adnan, Ather, et al.
Publicado: (2021)

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control
por: Ogura, Kengo, et al.
Publicado: (2013)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Study of Tumor Growth under Hyperthermia Condition
por: Zhu, Qing, et al.
Publicado: (2012)

Augmented Systemic Immunity in Mice Implanted with Tumor Necrosis Factor‐α Gene‐transduced Meth‐A Cells
por: Fujii, Shigeyuki, et al.
Publicado: (1994)

Anti‐tumor Effects of Hyperthermia Plus Granulocyte Colony‐stimulating Factor
por: Kokura, Satoshi, et al.
Publicado: (1996)

Synergistic Suppressive Effect of Double Transfection of Tumor Necrosis Factor‐α and Interleukin 12 Genes on Tumorigenicity of Meth‐A Cells
por: Fujiwara, Hitoshi, et al.
Publicado: (2000)

Local hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia
por: LIU, JIAYI, et al.
Publicado: (2013)

Intravenous Administration of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α Completely Regressed Solid Tumor in Meth‐A Murine Sarcoma Model
por: Tsutsumi, Yasuo, et al.
Publicado: (1994)

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor
Publicado: (1986)

The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors
por: Cheng, Yi, et al.
Publicado: (2019)

Transmembrane tumor necrosis factor alpha attenuates pressure-overload cardiac hypertrophy via tumor necrosis factor receptor 2
por: Miao, Kun, et al.
Publicado: (2020)

Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia.
por: Nishimura, Y., et al.
Publicado: (1996)

Tumor Necrosis Factor and Splenectomy
por: Yavaşoğlu, İrfan
Publicado: (2016)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

Early effects of tumor necrosis factor inhibition on bone homeostasis after soluble tumor necrosis factor receptor use
por: Lim, Mie Jin, et al.
Publicado: (2014)

In vivo Anti‐tumor Efficacy of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α against Tumor Necrosis Factor‐resistant Tumors
por: Tsutsumi, Yasuo, et al.
Publicado: (1996)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Risk factors for recurrence of Crohn's disease requiring surgery in patients receiving post-operative anti-tumor necrosis factor maintenance therapy
por: Araki, Toshimitsu, et al.
Publicado: (2018)

Tumor necrosis factor-α and muscle wasting: a cellular perspective
por: Reid, Michael B, et al.
Publicado: (2001)

Rugby ball-shaped magnetic microcapsule for tumor hyperthermia
por: Wang, Siyao, et al.
Publicado: (2023)

Inflammation, tumor necrosis factor, and toxicology.
por: Luster, M I
Publicado: (1998)

Tumor Necrosis Factor and Regulatory T Cells
por: Jung, Min Kyung, et al.
Publicado: (2019)

Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis
por: Atan, Denize, et al.
Publicado: (2013)

Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2
por: Fischer, Roman, et al.
Publicado: (2017)

RNPS1 inhibits excessive tumor necrosis factor/tumor necrosis factor receptor signaling to support hematopoiesis in mice
por: Zhong, Xue, et al.
Publicado: (2022)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
por: Schaer, David A, et al.
Publicado: (2014)

Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture
por: Chia, Daryl K. A., et al.
Publicado: (2023)

Tumor necrosis factor as a pharmacological target
por: Ghezzi, Pietro, et al.
Publicado: (2005)

Tumor Necrosis Factor: What Is in a Name?
por: Wang, Xinming, et al.
Publicado: (2022)

TNF Receptor 2 Makes Tumor Necrosis Factor a Friend of Tumors
por: Sheng, Yuqiao, et al.
Publicado: (2018)

A POSSIBLE ROLE OF GLUCOCORTICOIDS: AN INTRINSIC INHIBITOR OF THE CYTOTOXIC ACTIVITY OF TUMOR NECROSIS FACTOR
por: Abe, Shigeru, et al.
Publicado: (1988)

Tumor-specific hyperthermia with aptamer-tagged superparamagnetic nanoparticles
por: Pala, Katarzyna, et al.
Publicado: (2013)

Effective impairment of myeloma cells and their progenitors by hyperthermia
por: Miki, Hirokazu, et al.
Publicado: (2017)

Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
por: Mukaro, Violet R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gdc2bhu9a4uggouok8pt9erfua